Okupe, CFO of Hims & Hers, sells $275k in HIMS stock
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hims Hers Health Inc (HIMS)
Hims Hers Health Inc stock price live, this page displays NYSE HIMS stock exchange data. View the HIMS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hims Hers Health Inc real time stock price chart below.
What Is the Hims Hers Health Inc Stock Price Today?
The Hims Hers Health Inc stock price today is 29.06.
What Is the Stock Symbol for Hims Hers Health Inc?
The stock symbol for Hims Hers Health Inc is "HIMS."
What Stock Exchange Does Hims Hers Health Inc Trade On?
Hims Hers Health Inc is listed and trades on the NYSE stock exchange.
Is Hims Hers Health Inc a Good Stock to Buy?
Determining whether Hims Hers Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HIMS quote. (ISIN: US4330001060)
What Is the Hims Hers Health Inc Stock Price Today?
The Hims Hers Health Inc stock price today is 29.06.
What Is the Stock Symbol for Hims Hers Health Inc?
The stock symbol for Hims Hers Health Inc is "HIMS."
What Stock Exchange Does Hims Hers Health Inc Trade On?
Hims Hers Health Inc is listed and trades on the NYSE stock exchange.
Is Hims Hers Health Inc a Good Stock to Buy?
Determining whether Hims Hers Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HIMS quote. (ISIN: US4330001060)
Currency in USD
29.26
+0.59(+2.06%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
28.47
30.70
52 wk Range
23.97
72.98
HIMS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
28.4730.70
52 wk Range
23.9772.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HIMS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
41.62
Upside
+42.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 144 Hims & Hers Health For: 20 January
- Investing.com
- Okupe, CFO of Hims & Hers, sells $275k in HIMS stock
- Investing.com
- Form 144 Hims & Hers Health For: 20 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Hims Hers Health Inc Company Profile
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company’s curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. The company also provides Labs which measures key markers over time and provides doctor-developed action plans. Hims & Hers Health, Inc. is based in San Francisco, California.
Hims Hers Health Inc Earnings Call Summary for Q3/2025
- Hims & Hers Health Q3 2025 reported mixed results with EPS of $0.06 (missing $0.10 forecast) while revenue exceeded expectations at $600 million (up 49% YoY), driving a 3.45% aftermarket stock rebound.
- The company added 30,000 new subscribers sequentially (20% YoY growth) and achieved $78 million in adjusted EBITDA (50% YoY increase) with margins exceeding 13%.
- Management raised full-year 2025 guidance to $2.335-2.355 billion in revenue (58-59% YoY growth) and $307-317 million in adjusted EBITDA, maintaining a 13% margin.
- CEO Andrew Dudum outlined ambitious long-term targets of $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030, driven by new product launches and international expansion.
- New offerings in low testosterone and menopause treatments highlight the company's strategic focus on becoming 'the largest global consumer health platform.'
Last Updated: 2025-11-03, 06:28 p/m
Read Full TranscriptCompare HIMS to Peers and Sector
Metrics to compare | HIMS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHIMSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 48.8x | 8.4x | −0.6x | |
PEG Ratio | 2.35 | 0.04 | 0.00 | |
Price/Book | 11.2x | 0.9x | 2.6x | |
Price / LTM Sales | 3.0x | 0.9x | 3.4x | |
Upside (Analyst Target) | 29.1% | 41.1% | 43.4% | |
Fair Value Upside | Unlock | 30.1% | 6.3% | Unlock |
Analyst Ratings
3 Buy
10 Hold
2 Sell
Ratings:
15 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 41.62
(+42.23% Upside)
Earnings
Latest Release
Nov 03, 2025
EPS / Forecast
0.06 / 0.10
Revenue / Forecast
600.00M / 580.37M
People Also Watch
FAQ
What Is the Hims Hers Health (HIMS) Stock Price Today?
The Hims Hers Health stock price today is 29.26
What Stock Exchange Does Hims Hers Health Trade On?
Hims Hers Health is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Hims Hers Health?
The stock symbol for Hims Hers Health is "HIMS."
What Is the Hims Hers Health Market Cap?
As of today, Hims Hers Health market cap is 6.63B.
What Is Hims Hers Health's Earnings Per Share (TTM)?
The Hims Hers Health EPS (TTM) is 0.54.
When Is the Next Hims Hers Health Earnings Date?
Hims Hers Health will release its next earnings report on Mar 02, 2026.
From a Technical Analysis Perspective, Is HIMS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hims Hers Health Stock Split?
Hims Hers Health has split 0 times.
How Many Employees Does Hims Hers Health Have?
Hims Hers Health has 1637 employees.
What is the current trading status of Hims Hers Health (HIMS)?
As of Jan 29, 2026, Hims Hers Health (HIMS) is trading at a price of 29.26, with a previous close of 28.67. The stock has fluctuated within a day range of 28.47 to 30.70, while its 52-week range spans from 23.97 to 72.98.
What Is Hims Hers Health (HIMS) Price Target According to Analysts?
The average 12-month price target for Hims Hers Health is USD41.62, with a high estimate of USD85 and a low estimate of USD25. 3 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +42.23% Upside potential.
What Is the HIMS Premarket Price?
HIMS's last pre-market stock price is 28.90. The pre-market share volume is 172,720.00, and the stock has decreased by 0.23, or 0.80%.
What Is the HIMS After Hours Price?
HIMS's last after hours stock price is 28.69, the stock has decreased by 0.02, or 0.07%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.